Immunologic defects in severe mucocutaneous HSV-2 infections: Response to IFN-? therapy - 03/09/16
Doi : 10.1016/j.jaci.2016.02.025
Peer Arts, BSc a, Frank L. van de Veerdonk, MD, PhD b, Robin van der Lee, MSc c, Martijn A. Langereis, PhD d, Christian Gilissen, PhD a, Wendy A.G. van Zelst-Stams, MD, PhD a, Martijn A. Huynen, PhD c, Jos W.M. van der Meer, MD, PhD b, Frank J. van Kuppeveld, PhD d, Joris A. Veltman, PhD a, e, f, Bart Jan Kullberg, MD, PhD b, Alexander Hoischen, PhD a, e, Mihai G. Netea, MD, PhD b 
a Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands
b Department of Internal Medicine, and RadboudUMC Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands
c Centre for Molecular and Biomolecular Informatics, Radboud University Medical Center, Nijmegen, The Netherlands
d Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands
e Donders Centre for Cognitive Neuroimaging, Radboud University Nijmegen, Nijmegen, The Netherlands
f Department of Medical Genetics, Maastricht University Medical Centre, Maastricht, The Netherlands
| This study was supported by a grant from the Nijmegen Institute for Molecular Life Sciences (to A.H.). F.L.V., A.H. (grant no. 91612095), M.A.L. (grant no. 86313008), and C.G. (grant no. 91614043) were supported by Veni grants of the Netherlands Organization for Scientific Research. J.A.V. was supported by a European Research Council Starting Grant (grant no. 281964). R.L. and M.A.H. were supported by the Virgo consortium, funded by the Dutch government, and by the Netherlands Genomics Initiative. F.J.K. (grant no. 82002018) and M.G.N. (grant no. 91810610) were supported by Vici grants from the Netherlands Organization for Scientific Research. M.G.N. was supported by a European Research Council Consolidator Grant (grant no. 310372). |
|
| Disclosure of potential conflict of interest: F. L. van den Veerdonk, M. A. Langereis, C. Gilissen, F. J. van Kuppeveld, and A. Hoischen have received grants from the Netherlands Organization for Scientific Research. R. van der Lee and M. A. Huynen have received a grant from Virgo consortium, funded by the Dutch government, and by the Netherlands Genomics Initiative. J. A. Veltman has received a grant from the European Research Council (grant no. 281964). M. G. Netea has received grants from the Netherlands Organization for Scientific Research and the European Research Council (grant no. 310372). The rest of the authors declare that they have no relevant conflicts of interest. |
© 2016
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 138 - N° 3
P. 895-898 - septembre 2016 Retour au numéro
Article précédent
- The quest for autoreactive antibodies in nasal polyps
- Els De Schryver, Lien Calus, Henryk Bonte, De Ruyck Natalie, Hannah Gould, Erin Donovan, Dirk Elewaut, Rudolf Valenta, Irene Mittermann, Jan Gutermuth, Tanja Seher, Robert P. Schleimer, Bruce K. Tan, Lara Derycke, Thibaut Van Zele, Claus Bachert, Philippe Gevaert
- IL-1? enhances inflammatory TH2 differentiation
- Stephan M. Caucheteux, Jane Hu-Li, Liying Guo, Nisan Bhattacharyya, Michelle Crank, Michael T. Collins, William E. Paul
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?